Pancorbo S, Comty C
Antimicrob Agents Chemother. 1981 Apr;19(4):605-7. doi: 10.1128/AAC.19.4.605.
Teh pharmacokinetics of gentamicin were studied in seven chronic renal failure patients undergoing continuous ambulatory peritoneal dialysis. Patients received 100 mg of gentamicin in 2 liters of dialysate during an initial pass, and serum and dialysate samples were collected for gentamicin determination. Approximately 49% of the amount introduced into the peritoneal cavity was absorbed systemically during a 6-h cycle. Subsequent clearance of gentamicin from the serum occurred slowly with an elimination half-life of 36 h. Dialysis clearance of gentamicin during continuous ambulatory peritoneal dialysis was 2.94 ml/min.
在7例接受持续性非卧床腹膜透析的慢性肾衰竭患者中研究了庆大霉素的药代动力学。患者在初次透析时于2升透析液中加入100毫克庆大霉素，并采集血清和透析液样本以测定庆大霉素含量。在6小时的透析周期中，引入腹腔的庆大霉素约49%被全身吸收。随后血清中庆大霉素的清除缓慢，消除半衰期为36小时。持续性非卧床腹膜透析期间庆大霉素的透析清除率为2.94毫升/分钟。
